FAVI, EVALDO
FAVI, EVALDO
Dipartimento di Scienze Cliniche e di Comunità
3 Years Outcomes in a Randomized Trial Evaluating Everolimus Plus CNI Reduction in Kidney Transplant Recipients
2014 M. Salerno, V. Bianchi, E. Favi, G. Spagnoletti, J. Pedroso, A. Toscano, V. Pietroni, J. Romagnoli, F. Citterio
3 Years Outcomes in a Randomized Trial Evaluating Everolimus Plus CNI Reduction in Kidney Transplant Recipients
2014 M. Salerno, V. Bianchi, E. Favi, G. Spagnoletti, J. Pedroso, A. Toscano, V. Pietroni, J. Romagnoli, F. Citterio
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service
2023 F. Leonardis, L. Gitto, E. Favi, A. Oliva, R. Angelico, A. Mitterhofer, I. Cacciola, D. Santoro, T.M. Manzia, G. Tisone, R. Cacciola
A New Integrated Clinical-Histological Risk Score Index To Predict The 5-Year Kidney Graft Survival, Based On Data Available at The Time of Transplantation
2014 J. Pedroso, E. Favi, M. Salerno, G. Spagnoletti, P. Silvestri, V. Pietroni, A. Toscano, V. Bianchi, J. Romagnoli, F. Citterio
A prospective clinical trial comaring tacrolimus-MMF to cyclosporine-everolimus in de novo renal transplant recipients: 2 years results
2009 E. Favi, F. Citterio, G. Spagnoletti, A. Gargiulo, J. Romagnoli, M. Castagneto
A prospective clinical trial comparing tacrolimus-MMF to cyclosporine-everolimus in de novo renal transplant recipients: 2 years results
2009 E. Favi, F. Citterio, G. Spagnoletti, A. Gargiulo, J. Romagnoli, M. Castagneto
A prospective trial comparing tacrolimus with everolimus and low dose cyclosporine
2007 E. Favi, F. Citterio, G. Spagnoletti, V. Tondolo, J. Romagnoli, M. Castagneto
Abdominal aortic aneurysm in renal transplant recipients
2005 E. Favi, F. Citterio, V. Tondolo, A. Chirico, A. Brescia, J. Romagnoli, M. Castagneto
Adipose-derived stem/stromal cells in kidney transplantation: Status quo and future perspectives
2021 G. Storti, E. Favi, F. Albanesi, B.-. Kim, V. Cervelli
Allograft artery mycotic aneurysm after kidney transplantation: A case report and review of literature
2020 M. Bindi, M. Ferraresso, M.L. De Simeis, N. Raison, L. Clementoni, S. Delbue, M. Perego, E. Favi
Allograft Vesicoureteral Reflux after Kidney Transplantation
2022 A. Brescacin, S. Iesari, S. Guzzo, C.M. Alfieri, R. Darisi, M. Perego, C. Puliatti, M. Ferraresso, E. Favi
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
2021 V. Binda, E. Favi, M. Calatroni, G. Moroni
BK POLYOMAVIRUS INFECTION AFTER KIDNEY TRANSPLANTATION: 5-YEAR RESULTS OF A SINGLE-CENTRE OBSERVATIONAL STUDY
2019 E. Favi, F. Ambrogi, C. Puliatti, S. Delbue, M. Ferraresso, R. Cacciola
Bone and Mineral Disorder in Renal Transplant Patients: Overview of Pathology, Clinical, and Therapeutic Aspects
2022 P. Molinari, C.M. Alfieri, D. Mattinzoli, M. Campise, A. Cervesato, S. Malvica, E. Favi, P. Messa, G. Castellano
Bone effect and safety of one-year denosumab therapy in a Cohort of renal transplanted patients : an observational monocentric study
2021 C. Alfieri, V. Binda, S. Malvica, D. Cresseri, M. Campise, M.T. Gandolfo, A. Regalia, D. Mattinzoli, S. Armelloni, E. Favi, P. Molinari, P. Messa
Bone effects and safety of one year denosumab therapy in a cohort of renal transplanted patients: An observational monocentric study
2021 C.M. Alfieri, V. Binda, M.T. Gandolfo, D. Cresseri, M.R. Campise, S. Malvica, E. Favi, P. Messa
Bortezomib-containing multimodality treatment for antibody-mediated rejection with anti-HLA and anti-AT1R antibodies after kidney transplantation
2017 S. Iesari, Q. Lai, E. Favi, F. Pisani
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine
2009 G. Spagnoletti, F. Citterio, E. Favi, E. Rossi, F. Delreno, I. De Santis, M.P. Salerno, A. Gargiulo, M. Castagneto
Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: Tacrolimus-MMF-Prednisone vs Everolimus-low dose Cyclosporine-Prednisone
2008 E. Favi, F. Citterio, G. Spagnoletti, I. De Santis, F. Delreno, J. Romagnoli, A. Gargiulo, A. Maida, M. Castagneto
Case report: Eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-HUS
2022 E. Favi, P. Molinari, C. Alfieri, G. Castellano, M. Ferraresso, D. Cresseri